title: Do you approve of spending $300 million on HPV vaccination?: no.
authors.affiliation: McGill University, 1020 Pine Ave W, Montreal, QC. abby.lippman@mcgill.ca
authors.forename: Abby
authors.initials: A
authors.lastname: Lippman
authors.forename: Madeline
authors.initials: M
authors.lastname: Boscoe
authors.forename: Carol
authors.initials: C
authors.lastname: Scurfield
mesh_terms: D052685:Alphapapillomavirus; D002170:Canada; D005260:Female; D005102:Health Expenditures; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D008403:Mass Screening; D030361:Papillomavirus Infections / Q000453:epidemiology* / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000191:economics*; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000821:virology; D014626:Vaginal Smears
chemical_list: D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines